Skip to content

Safety and feasiblity of iEat as a diet for esophago-gastric-duodenal endoscopy

Safety and feasiblity of iEat as a diet for esophago-gastric-duodenal endoscopy on the patients undergoing gastrecomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1050200100
Enrollment
30
Registered
2020-12-21
Start date
2020-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer gastric cancer, gastrectomy

Interventions

Use of iEat for EGD examination on gastrectomized patients

Sponsors

Miyazaki Yasuhiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients who were 20 years old or older of age at the time of giving consent (2)Patients undergoing for distal gastrectomy, pylorus-preserving gastrectomy, proximal gastrectomy (3)Patients who underwent R0 resection (4)Patients with gastric cancer pStage under stage IIIC (5)Patients who underwent gastrecomty within 5 years (6)Patients with residue in the remnant stomach during gastric endoscopy, which correspond to R grade over grade 2 in the RGB classification

Exclusion criteria

Exclusion criteria: (1)Patients who schedule the first gastric endoscopy after gastrectomy (2)Patients with a performance status (PS) score of 0 - 2 on the ECOG scale (3)Patients otherwise considered inappropriate by a medical doctor

Design outcomes

Primary

MeasureTime frame
Number and rate of patients who are required to re-endoscopic examination

Secondary

MeasureTime frame
Time for endoscopy (judged by the image of endoscopic pictures) Residue in the remnant stomach at the first and the end of endosopic examination R grade accoding to RGB classification

Contacts

Public ContactYasuhiro Miyazaki

Osaka Genaral Medical Center

ymiyazaki02@gh.opho.jp+81-666921201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026